Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner

被引:23
作者
Gai, Xiaoxiao [1 ,2 ]
Zhao, Peiqing [1 ,2 ,3 ]
Pan, Yingfang [1 ,2 ]
Shan, Haixia [1 ,2 ]
Yue, Xuetian [1 ,2 ]
Du, Juan [4 ]
Zhang, Zhenyu [1 ,2 ]
Liu, Peng [1 ,2 ]
Ma, Hongxin [1 ,2 ]
Guo, Min [1 ,2 ]
Yang, Xiaoyun [5 ]
Sun, Wensheng [1 ,2 ]
Gao, Lifen [1 ,2 ]
Ma, Chunhong [1 ,2 ]
Liang, Xiaohong [1 ,2 ]
机构
[1] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Sch Med, Inst Immunol, Jinan 250012, Shandong, Peoples R China
[3] Cent Hosp Zibo City, Zibo 255036, Shandong, Peoples R China
[4] Qianfo Shan Hosp, Cent Lab, Jinan 250014, Shandong, Peoples R China
[5] Shandong Univ, Qilu Hosp, Ctr Phys Examinat, Jinan 250012, Shandong, Peoples R China
基金
美国国家科学基金会;
关键词
Hepatitis B virus core (HBc); Hepatocellular carcinoma (HCC); Human telomerase reverse transcriptase (hTERT); Transcription activation; c-Ets2; CHRONIC LIVER-DISEASE; TRANSGENIC MICE; UP-REGULATION; MAP KINASE; GENE; PATHWAY; CANCER; ACTIVATION; HEPATOCARCINOGENESIS; PATHOGENESIS;
D O I
10.1016/j.biocel.2013.03.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis B virus core protein can regulate viral replication and host gene expression. However, it is unclear whether and how hepatitis B virus core protein regulates hepatocellular carcinoma cell proliferation. Induction of hepatitis B virus core protein over-expression significantly enhanced the proliferation of hepatocellular carcinoma cells, while knockdown of hepatitis B virus core protein expression inhibited the proliferation of hepatocellular carcinoma cells. Altered hepatitis B virus core protein expression significantly changed the growth of implanted hepatocellular carcinoma in vivo. Microarray analysis indicated that hepatitis B virus core protein up-regulated human telomerase reverse transcriptase expression, which was further validated by over-expression and knockdown assays in vitro. Furthermore, knockdown of human telomerase reverse transcriptase expression mitigated the hepatitis B virus core protein-enhanced hepatocellular carcinoma cell proliferation and clone formation in vitro. Luciferase assays indicated that hepatitis B virus core protein enhanced the promoter activity of human telomerase reverse transcriptase, which was dependent on the binding of c-Ets2 to the promoter region between 192 and -187. In addition, hepatitis B virus core protein enhanced human telomerase reverse transcriptase transcription in HepG2 cells, but not in the c-Ets2-silencing HepG2 cells. Moreover, hepatitis B virus core protein promoted c-Ets2 nuclear translocation. Finally, significantly higher levels of human telomerase reverse transcriptase expression and nuclear c-Ets2 accumulation were detected in hepatitis B virus core protein-positive hepatocellular carcinoma samples. Our findings demonstrate that hepatitis B virus core protein promotes hepatocellular carcinoma cell proliferation by up-regulating the c-Ets2-dependent expression of human telomerase reverse transcriptase. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1174 / 1185
页数:12
相关论文
共 49 条
[41]   c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma [J].
Wu, Yan-Hui ;
Ai, Xi ;
Liu, Fu-Yao ;
Liang, Hui-Fang ;
Zhang, Bi-Xiang ;
Chen, Xiao-Ping .
MOLECULAR MEDICINE REPORTS, 2016, 13 (02) :1345-1352
[42]   Hepatitis B virus X protein promotes tumor invasion and poor prognosis in hepatocellular carcinoma via phosphorylation of paxillin at Serine 178 by activation of the c-Jun NH2-terminal kinase [J].
Chen, Ming-Jenn ;
Wu, De-Wei ;
Shen, Ching-Ju ;
Cheng, Ya-Min ;
Wu, Cheng-Chung ;
Lee, Huei .
AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (01) :275-+
[43]   Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma [J].
Tang, Shaohui ;
Hu, Wei ;
Hu, Jianjun ;
Wu, Shenglan ;
Li, Junfeng ;
Luo, Yuhong ;
Cao, Mingrong ;
Zhou, Hongke ;
Jiang, Xiangwu .
LIVER INTERNATIONAL, 2015, 35 (02) :608-619
[44]   Decreased Expression of Hepatocyte Nuclear Factor 4α (Hnf4α)/MicroRNA-122 (miR-122) Axis in Hepatitis B Virus-associated Hepatocellular Carcinoma Enhances Potential Oncogenic GALNT10 Protein Activity [J].
Wu, Qian ;
Liu, Hai-Ou ;
Liu, Yi-Dong ;
Liu, Wei-Si ;
Pan, Deng ;
Zhang, Wei-Juan ;
Yang, Liu ;
Fu, Qiang ;
Xu, Jie-Jie ;
Gu, Jian-Xin .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (02) :1170-1185
[45]   Hepatitis C virus Core protein overcomes all-trans retinoic acid-induced cell growth arrest by inhibiting retinoic acid receptor-β2 expression via DNA methylation [J].
Lee, Hyehyeon ;
Woo, Young-Ju ;
Kim, Soo Shin ;
Kim, Sung-Hyun ;
Park, Bum-Joon ;
Choi, Dongho ;
Jang, Kyung Lib .
CANCER LETTERS, 2013, 335 (02) :372-379
[46]   rt269L-Type hepatitis B virus (HBV) in genotype C infection leads to improved mitochondrial dynamics via the PERK-eIF2α-ATF4 axis in an HBx protein-dependent manner [J].
Choi, Yu-Min ;
Kim, Dong Hyun ;
Jang, Junghwa ;
Choe, Won Hyeok ;
Kim, Bum-Joon .
CELLULAR & MOLECULAR BIOLOGY LETTERS, 2023, 28 (01)
[47]   Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line [J].
Erhardt, A ;
Hassan, M ;
Heintges, T ;
Häussinger, D .
VIROLOGY, 2002, 292 (02) :272-284
[48]   Hepatitis C virus NS3 protein enhances cancer cell invasion by activating matrix metalloproteinase-9 and cyclooxygenase-2 through ERK/p38/NF-κB signal cascade [J].
Lu, Lili ;
Zhang, Qi ;
Wu, Kailang ;
Chen, Xi ;
Zheng, Yi ;
Zhu, Chengliang ;
Wu, Jianguo .
CANCER LETTERS, 2015, 356 (02) :470-478
[49]   7-Methoxy-1-Tetralone Induces Apoptosis, Suppresses Cell Proliferation and Migration in Hepatocellular Carcinoma via Regulating c-Met, p-AKT, NF-κB, MMP2, and MMP9 Expression [J].
Wen, Ying ;
Cai, Xiaoyan ;
Chen, Shaolian ;
Fu, Wei ;
Chai, Dong ;
Zhang, Huainian ;
Zhang, Yongli .
FRONTIERS IN ONCOLOGY, 2020, 10